158 related articles for article (PubMed ID: 20544219)
1. Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.
Kater B; Hunold A; Schmalz HG; Kater L; Bonitzki B; Jesse P; Prokop A
J Cancer Res Clin Oncol; 2011 Apr; 137(4):639-49. PubMed ID: 20544219
[TBL] [Abstract][Full Text] [Related]
2. (2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in Leukemia and Lymphoma Cells In Vitro.
Wilke N; Frias C; Berkessel A; Prokop A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731935
[TBL] [Abstract][Full Text] [Related]
3. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
[TBL] [Abstract][Full Text] [Related]
4. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.
Kater L; Kater B; Jakupec MA; Keppler BK; Prokop A
J Biol Inorg Chem; 2021 Dec; 26(8):897-907. PubMed ID: 34617137
[TBL] [Abstract][Full Text] [Related]
5. The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells.
Lee SY; Peckermann I; Abinet E; Okuda J; Henze G; Prokop A
Med Oncol; 2012 Mar; 29(1):235-42. PubMed ID: 21191668
[TBL] [Abstract][Full Text] [Related]
6. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo.
Zhou Q; Li Y; Jin J; Lang L; Zhu Z; Fang W; Chen X
Biol Pharm Bull; 2012; 35(12):2170-9. PubMed ID: 23207769
[TBL] [Abstract][Full Text] [Related]
7. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
8. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
9. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
Li L; Ma L; Sun J
Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
[TBL] [Abstract][Full Text] [Related]
10. [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Lee SY; Hille A; Kitanovic I; Jesse P; Henze G; Wölfl S; Gust R; Prokop A
Leuk Res; 2011 Mar; 35(3):387-93. PubMed ID: 21131047
[TBL] [Abstract][Full Text] [Related]
11. The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.
Kater L; Claffey J; Hogan M; Jesse P; Kater B; Strauss S; Tacke M; Prokop A
Toxicol In Vitro; 2012 Feb; 26(1):119-24. PubMed ID: 21986259
[TBL] [Abstract][Full Text] [Related]
12. Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma.
Zheng J; Zeng L; Tang M; Lin H; Pi C; Xu R; Cui X
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803555
[TBL] [Abstract][Full Text] [Related]
13. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
Barancík M; Bohácová V; Sedlák J; Sulová Z; Breier A
Eur J Pharm Sci; 2006 Dec; 29(5):426-34. PubMed ID: 17010577
[TBL] [Abstract][Full Text] [Related]
14. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
15. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.
An N; Sun Y; Ma L; Shi S; Zheng X; Feng W; Shan Z; Han Y; Zhao L; Wu H
Arch Med Res; 2020 Apr; 51(3):224-232. PubMed ID: 32147288
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.
Podolski-Renić A; Bősze S; Dinić J; Kocsis L; Hudecz F; Csámpai A; Pešić M
Metallomics; 2017 Aug; 9(8):1132-1141. PubMed ID: 28737782
[TBL] [Abstract][Full Text] [Related]
17. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
[TBL] [Abstract][Full Text] [Related]
18. Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria.
de Vries JF; Wammes LJ; Jedema I; van Dreunen L; Nijmeijer BA; Heemskerk MH; Willemze R; Falkenburg JH; Barge RM
Apoptosis; 2007 Jan; 12(1):181-93. PubMed ID: 17136321
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
20. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
